IP Library › Assignment 057988/0232
Patent Assignment
Reel/Frame 057988/0232

Security Interest

Recorded: 2021-10-04 Pages: 16
Assignor
TARVEDA THERAPEUTICS, INC.
Executed: 2021-09-30
Assignee
OXFORD FINANCE LLC
115 SOUTH UNION STREET, SUITE 3000, ALEXANDRIA, VIRGINIA, 22314
Covered Properties (72)
Targeted Conjugates Encapsulated in Particles and Formulations Thereof
Targeted Conjugates and Particles and Formulations Thereof
Targeted Conjugates and Particles and Formulations Thereof
Compositions and Methods for Immunomodulation
Compositions and Methods for Immuno-Oncology Therapies
HSP90-Targeting Conjugates and Formulations Thereof
HSP90-Binding Conjugates and Formulations Thereof
Sstr-Targeted Conjugates and Formulations Thereof
HSP90-Binding Conjugates and Combination Therapies Thereof
Targeted Conjugates and Particles and Formulations Thereof
Patent: 9,750,818 →
Application: 15/382,487 →
Publication: US 2017/0095569
Targeted Conjugates and Particles and Formulations Thereof
Application: 15/652,947 →
Publication: US 2018/0000959
Targeted Conjugates and Particles and Formulations Thereof
Application: 15/652,957 →
Publication: US 2017/0312245
Combination Therapy
Application: 15/734,110 →
Publication: US 2021/0186978
Sstr-Targeted Conjugates and Particles and Formulations Thereof
Application: 15/770,513 →
Publication: US 2018/0221499
HSP90 Targeted Conjugates and Particles and Formulations Thereof
Application: 16/079,387 →
Publication: US 2019/0054072
Sstr-Targeted Conjugates and Particles and Formulations Thereof
Application: 16/345,306 →
Publication: US 2019/0262460
HSP90-Targeting Conjugates and Formulations Thereof
Application: 16/469,768 →
Publication: US 2020/0085960
Targeted Therapeutics
Application: 16/625,358 →
Publication: US 2020/0230126
Combination Therapies Comprising Targeted Therapeutics
Application: 16/625,362 →
Publication: US 2020/0230247
HSP90 Targeted Conjugates and Particle Formulations Thereof
Application: 16/625,368 →
Publication: US 2020/0237746
HSP90 Targeted Conjugates and Particles and Formulations Thereof
Application: 16/711,577 →
Publication: US 2020/0113877
Sstr-Targeted Conjugates Encapsulated in Particles and Formulations Thereof
Application: 16/722,913 →
Publication: US 2020/0121808
Sstr-Targeted Conjugates and Formulations Thereof
Application: 16/759,438 →
Publication: US 2020/0281934
HSP90-Targeting Conjugates and Formulations Thereof
Application: 16/772,290 →
Publication: US 2021/0000966
Targeted Conjugates and Particles and Formulations Thereof
Application: 16/793,094 →
Publication: US 2020/0206356
HSP90-Targeting Conjugates and Formulations Thereof
Application: 17/045,320 →
Publication: US 2021/0145971
Pharmaceutical Compositions with Reduced Tert-Butanol Levels
Application: 17/045,325 →
Publication: US 2021/0169871
Nanoparticulate Targeted Drug Delivery
Application: 61/746,866 →
Targeted Conjugates Encapsulated in Particles and Formulations Thereof
Application: 62/019,001 →
Targeted Conjugates Encapsulated in Particles and Formulations Thereof
Application: 62/019,003 →
Particles Incorporating Drug Conjugates of Targeting Scaffolds and Formulations Thereof
Application: 62/020,615 →
Targeted Conjugates Encapsulated in Particles and Formulations Thereof
Application: 62/077,487 →
Targeted Conjugates Encapsulated in Particles and Formulations Thereof
Application: 62/084,306 →
Targeted Conjugates and Particles and Formulations Thereof
Application: 62/102,261 →
Targeted Conjugates and Particles and Formulations Thereof
Application: 62/150,413 →
Compositions and Methods for Immuno-Oncology Therapies
Application: 62/199,414 →
Compositions and Methods for Immunomodulation
Application: 62/199,422 →
Sstr-Targeted Conjugates and Particles and Formulations Thereof
Application: 62/247,336 →
HSP90 Targeted Conjugates and Particles and Formulations Thereof
Application: 62/298,917 →
Sstr-Targeted Conjugates and Particles and Formulations Thereof
Application: 62/304,856 →
Compositions and Methods for Immuno-Oncology Therapies
Application: 62/332,772 →
Compositions and Methods for Immunomodulation
Application: 62/332,838 →
HSP90 Targeted Conjugates and Particles and Formulations Thereof
Application: 62/351,716 →
Sstr-Targeted Conjugates and Particles and Formulations Thereof
Application: 62/414,481 →
HSP90-Targeting Conjugates and Formulations Thereof
Application: 62/434,282 →
HSP90-Targeting Conjugates and Formulations Thereof
Application: 62/449,260 →
HSP90-Targeting Conjugates and Formulations Thereof
Application: 62/487,726 →
Targeted Therapeutics
Application: 62/522,316 →
Combination Therapies Comprising Targeted Therapeutics
Application: 62/522,323 →
Sstr-Targeted Conjugates and Particles and Formulations Thereof
Application: 62/577,897 →
HSP90-Targeting Conjugates and Formulations Thereof
Application: 62/598,755 →
Targeted Therapeutics
Application: 62/642,154 →
HSP90-Targeting Conjugates and Formulations Thereof
Application: 62/653,106 →
Pharmaceutical Compositions with Reduced Tert-Butanol Levels
Application: 62/653,118 →
Combination Therapy
Application: 62/679,216 →
Combination Therapies Comprising Targeted Therapeutics
Application: 62/679,224 →
Sstr-Targeted Conjugates and Formulations Thereof
Application: 62/679,230 →
HSP90-Targeting Conjugates and Formulations Thereof
Application: 62/684,666 →
HSP90-Targeting Conjugates and Formulations Thereof
Application: 62/731,538 →
HSP90-Targeting Conjugates and Formulations Thereof
Application: 62/731,543 →
HSP90-Targeting Conjugates and Formulations Thereof
Application: 62/731,545 →
HSP90-Targeting Conjugates and Formulations Thereof
Application: 62/735,306 →
HSP90-Targeting Conjugates and Formulations Thereof
Application: 62/757,955 →
HSP90-Targeting Conjugates and Formulations Thereof
Application: 62/787,799 →
Combination Therapy
Application: 62/788,326 →
Combination Therapy
Application: 62/827,232 →
HSP90-Targeting Conjugates and Formulations Thereof
Application: 62/828,645 →
Sstr-Targeted Conjugates and Formulations Thereof
Application: 62/866,134 →
HSP90-Binding Conjugates and Combination Therapies Thereof
Application: 62/866,140 →
Targeted Therapeutics
Application: 62/899,777 →
HSP90-Binding Conjugates and Formulations Thereof
Application: 62/986,245 →
HSP90-Binding Conjugates and Combination Therapies Thereof
Application: 63/035,048 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 14, 2014
From: BILODEAU, MARK T.; KADIYALA, SUDHAKAR; SHINDE, RAJESH; WHITE, BRIAN
To: BLEND THERAPEUTICS, INC.
Reel/Frame 032663/0242 →
Assignment of Assignor's Interest Oct 7, 2014
From: BILODEAU, MARK T.; KADIYALA, SUDHAKAR; SHINDE, RAJESH; WHITE, BRIAN
To: BLEND THERAPEUTICS, INC.
Reel/Frame 033904/0360 →
Assignment of Assignor's Interest May 27, 2015
From: MOREAU, BENOÎT
To: BLEND THERAPEUTICS, INC.
Reel/Frame 035718/0344 →
Assignment of Assignor's Interest Oct 13, 2015
From: ALARGOVA, ROSSITZA G.; BILODEAU, MARK T.; DUNBAR, CRAIG A.; KADIYALA, SUDHAKAR
To: BLEND THERAPEUTICS, INC.
Reel/Frame 036781/0900 →
Assignment of Assignor's Interest Oct 15, 2015
From: WHITE, BRIAN H.; ALARGOVA, ROSSITZA G.; BAZINET, PATRICK ROSAIRE; DUNBAR, CRAIG A.
To: BLEND THERAPEUTICS, INC.
Reel/Frame 036873/0784 →
Change of Name Jan 28, 2016
From: BLEND THERAPEUTICS, INC.
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 037629/0907 →
Assignment of Assignor's Interest Aug 1, 2016
From: KADIYALA, SUDHAKAR; WARD, DONNA T.
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 039307/0302 →
Assignment of Assignor's Interest Aug 1, 2016
From: KADIYALA, SUDHAKAR; WOOSTER, RICHARD; WARD, DONNA T.
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 039307/0282 →
Change of Name Apr 10, 2017
From: BLEND THERAPEUTICS, INC.
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 042201/0282 →
Assignment of Assignor's Interest Apr 10, 2017
From: ALARGOVA, ROSSITZA G.; BILODEAU, MARK T.; DUNBAR, CRAIG A.; KADIYALA, SUDHAKAR
To: BLEND THERAPEUTICS, INC.
Reel/Frame 041948/0908 →
Change of Name Jul 20, 2017
From: BLEND THERAPEUTICS, INC.
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 043269/0688 →
Change of Name Jul 20, 2017
From: BLEND THERAPEUTICS, INC.
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 043269/0617 →
Assignment of Assignor's Interest Jul 20, 2017
From: ALARGOVA, ROSSITZA G.; BILODEAU, MARK T.; DUNBAR, CRAIG A.; KADIYALA, SUDHAKAR
To: BLEND THERAPEUTICS, INC.
Reel/Frame 043052/0964 →
Assignment of Assignor's Interest Jul 20, 2017
From: ALARGOVA, ROSSITZA G.; BILODEAU, MARK T.; DUNBAR, CRAIG A.; KADIYALA, SUDHAKAR
To: BLEND THERAPEUTICS, INC.
Reel/Frame 043052/0879 →
Assignment of Assignor's Interest Apr 24, 2018
From: WOOSTER, RICHARD; WHALEN, KERRY; BAZINET, PATRICK ROSAIRE; BILODEAU, MARK T.
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 045618/0490 →
Assignment of Assignor's Interest Oct 18, 2018
From: SHINDE, RAJESH R.; BILODEAU, MARK T.; WOOSTER, RICHARD; KADIYALA, SUDHAKAR
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 047221/0611 →
Assignment of Assignor's Interest Apr 29, 2019
From: SHINDE, RAJESH R.; ALARGOVA, ROSSITZA G.; LIM SOO, PATRICK; SWERYDA-KRAWIEC, BEATA
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 049020/0938 →
Assignment of Assignor's Interest Jun 19, 2019
From: MOREAU, BENOÎT; WHITE, BRIAN H.; BILODEAU, MARK T.; SIMCOX, MARY
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 049515/0786 →
Assignment of Assignor's Interest Oct 16, 2019
From: WHITE, BRIAN H.; MOREAU, BENOÎT; CIPRIANI, TYLER; BILODEAU, MARK T.
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 050737/0293 →
Assignment of Assignor's Interest Jan 6, 2020
From: WOOSTER, RICHARD; WHALEN, KERRY; SIMCOX, MARY; ALLAND, LEILA
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 051423/0676 →
Assignment of Assignor's Interest Jan 6, 2020
From: ALLAND, LEILA; SEARS, CHRISTOPHER; SHINDE, RAJESH R.; SWERYDA-KRAWIEC, BEATA
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 051422/0390 →
Assignment of Assignor's Interest Jan 6, 2020
From: BILODEAU, MARK T.; KADIYALA, SUDHAKAR; SHINDE, RAJESH; WHITE, BRIAN
To: BLEND THERAPEUTICS, INC.
Reel/Frame 051423/0393 →
Assignment of Assignor's Interest Jan 6, 2020
From: MOREAU, BENOÎT
To: BLEND THERAPEUTICS, INC.
Reel/Frame 051423/0455 →
Assignment of Assignor's Interest Jan 6, 2020
From: SHINDE, RAJESH R.; BILODEAU, MARK T.; WOOSTER, RICHARD; KADIYALA, SUDHAKAR
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 051423/0800 →
Change of Name Jan 6, 2020
From: BLEND THERAPEUTICS, INC.
To: TARVEDA THERAPEUTICS, INC.
Reel/Frame 051485/0705 →